About COVID-19 Vaccines in Vermont

About COVID-19 Vaccines in Vermont

Vaccines are the best tool to help slow the spread of COVID-19. Vaccines help your body fight off the virus and keep you from getting sick. The more people who get vaccinated, the faster we can end the COVID-19 pandemic.

The Health Department is working closely with the Centers for Disease Control and Prevention (CDC) and other partners to distribute vaccines as they become available. Our goal is to administer every available dose each week. 

COVID-19 vaccines are provided to Vermonters at no cost.

getting the vaccine

Vermont's Commissioner of Health, Mark Levine, MD, addresses common questions about the COVID-19 vaccine.

 

 

Vaccines for Children

On May 10, the U.S. Food and Drug Administration authorized the Pfizer COVID-19 vaccine for emergency use in people 12-15 years old. On May 12, the CDC's Advisory Committee on Immunization Practices, a panel of public health and medical experts who make recommendations to CDC, recommended the vaccine. The CDC adopted the recommendation. Vermont has started administering the first doses of COVID-19 vaccine to 12-15-year-olds. 

Clinical trials of the Pfizer vaccine among kids ages 12-15 showed that the vaccine is safe and effective for that age group. None of the children who got the Pfizer vaccine during the clinical trial got sick with COVID-19. Getting vaccinated means more freedom so Vermont kids can be kids, including staying in school if they're a close contact.

What You Need to Know About COVID-19 Vaccines for Kids
Arabic | Burmese | Chinese – Simplified | Chinese - Traditional | English | French | Hindi | Karen | Kirundi | Nepali Portuguese | Somali | Spanish | Swahili | Thai | Tibetan | Vietnamese

The Science Behind the COVID-19 Vaccine: Parent FAQs (American Academy of Pediatrics)

Learn more about the benefits of getting your teen vaccinated from Dr. Andrea Green and the Vermont Multilingual Coronavirus Task Force:
Arabic | Burmese | French | Kirundi | Maay Maay | Nepali | Somali | Spanish | Swahili | Vietnamese

Moderna and Johnson & Johnson are each running clinical vaccine trials with adolescents aged 12 to 17. Pfizer-BioNTech and Moderna have clinical trials of their vaccines for younger children going on now. 

Learn More

Anyone aged 12 and older is eligible to be vaccinated. Make an appointment or find a walk-in clinic. In addition to Health Department communications, we work with partners like health care practices, community organizations, pharmacies, employers, and local news media to announce updates in eligibility, vaccine access, and other important vaccine information.

How Decisions Are Made

The Health Department works with State leadership to make these difficult choices after considering recommendations from the Advisory Committee on Immunization Practices, CDC, and Vermont’s Vaccine Implementation Advisory Committee. Based on our data, we know that focusing next on providing vaccine to people based on their age and whether they have certain high-risk health conditions will help us save lives.

Equity is also a consideration in our vaccination efforts. We are committed to addressing the historical and current factors that contribute to health disparities. Members of certain demographic groups have been disproportionately overrepresented in Vermont’s COVID-19 infection, hospitalization, and death rates. Because of these increased risks, historical harms and the resulting mistrust of health care and public health, we will ensure that Black, Indigenous and people of color in Vermont community gets the support they need, in the language they need, in the locations they need, to make informed choices and to get scheduled for vaccinations.

Working toward equity

As part of our strategy to prioritize Vermonters most at risk of severe illness and save lives, we have also begun vaccinating Vermonters in communities that have unique needs, such as people who speak languages other than English and people who are homebound. This requires us to meet people where they are and find ways to reduce known barriers to vaccine access where we can. We will continue to do this as more vaccine becomes available and we are able to reach more people in Vermont. Below are some examples of ways we are working to meet Vermonters where they are to work toward equitable access to COVID-19 vaccines.

Vermonters who are Black, Indigenous and People of Color (BIPOC)

We still have much more to do to address the significant disparities in the rates of COVID-19 infection, hospitalization, and death among Vermonters who are Black, Indigenous and people of color (BIPOC). Right now we are working with funded community partners to understand the barriers that might limit vaccine access for BIPOC Vermonters, as these require unique public health solutions. This coordinated vaccination effort is an important step in working with and compensating trusted community partner networks to reach some of the most historically marginalized people in Vermont. 

Who are BIPOC?
Anyone who is Black, Brown, Asian (AAPI or APIDA), Indigenous/First Nations/Abenaki, African American, Hispanic, Latino/Latina/Latinx, mixed race, or biracial.

AAPI stands for Asian American and Pacific Islander. APIDA stands for Asian, Pacific Islander, Desi American. Desi is a pan-ethnic term used to refer to people from South Asia.

People Who Speak Languages Other Than English

The Health Department has begun holding clinics for Vermonters who are eligible by their age grouping — and their family members age 12 and older — who need safe access to linguistically and culturally appropriate services. We work with cultural liaisons, have interpreters on hand or easily accessible, and provide accurately translated materials for these Vermonters. 

We understand that language barriers and other factors faced by immigrant and refugee communities have led to outbreaks, disproportionate outcomes, and a markedly greater risk of COVID-19. It makes good public health sense to allow families and households facing language and access barriers to get information and services at the same time, rather than duplicate these services later on. 

Migrant farm worker vaccination initiative  

To ensure equitable access to vaccine for migrant farm workers, we are working closely with our local health offices across the state, along with partners Bridges to Health and the Open Door Clinic, who have established connections to migrant agricultural communities. Little Rivers Health Care is supporting these efforts in the Upper Valley region of Vermont. The initiative has started in Addison County, with plans in place to expand across Vermont. These small, on-site vaccinations are being customized to meet the needs of different farms that are home to congregate living spaces. They are for farm workers who meet the current eligibility criteria, along with fellow farm workers living in the same household. 

People Who Are Homebound

The Health Department is coordinating vaccination for people who are homebound through a partnership between local home health and EMS agencies.

This includes people who are eligible by their age grouping and are both homebound and in the service of local home health agencies (including both VNA agencies and Bayada).

We know that there are homebound community members who do not receive home health services who will need to be vaccinated. Once the group of homebound people who are connected to home health agencies are vaccinated, we will expand this service by reaching out through numerous partners, including primary care, Agencies on Aging, and municipalities to identify people to include in the second phase of outreach.

About the Vaccines

Which vaccines are available in Vermont?

Three COVID-19 vaccines have received Emergency Use Authorization from the U.S. Food and Drug Administration (FDA).

An EUA is a way for vaccines and other medicines to be approved in a public health emergency. After proving the vaccines are safe and effective, they can be used while long term studies continue. Learn more about Emergency Use Authorization and watch a video on what an EUA is.

Which vaccine will I get?

If you are making an appointment through the Health Department system, you will see the name of the vaccine listed after the “event” description. However, there is no way to search for an appointment based on which vaccine is available. Please note that only sites with the Pfizer-BioNTech vaccine will show up for people age 12 - 17 since that is the only vaccine that has been authorized for people age 12 and older. For the two-dose vaccines (Pfizer-BioNTech and Moderna), you should get the same vaccine for both your first and second dose.

About vaccine efficacy

All three vaccines are safe and similarly effective at preventing severe illness and death. This standard is what is most commonly used to assess other vaccines like the flu shot. We cannot directly compare the efficacy of the three vaccines because they were not studied against each other at the same time. Each clinical trial had different study protocols, timing and location. For example, variants weren’t widely circulating when the earlier vaccines were being tested.

The CDC and FDA continue to assess the vaccines’ effectiveness as they are distributed. There are several things that can affect how well vaccines work in real-world settings (as opposed to clinical trial settings). The vaccines being administered now are going to millions of people, while trials enrolled tens of thousands each. The sheer number of people being vaccinated now may mean individual reactions that were different from those who participated in the trials. A vaccine’s effectiveness also depends on things like variants, the amount of virus in your community or differences in administering vaccines like dosing schedules and vaccine handling in different settings.

Virus Variants

Viruses constantly change through mutation. New variants and strains are expected. Many emerge and disappear, but others can persist and even become the most common strain. Some variants are more concerning than others. The less a virus spreads, the fewer chances for it to mutate into different variants. This is why prevention steps, including vaccines, are so important.

Right now there are a few different variants of concern. Some variants spread more easily from one person to another. Current data suggest that COVID-19 vaccines authorized for use in the United States offer protection against most variants currently spreading in the United States. This is being closely investigated and more studies are happening now. The best way to protect yourself against the virus and variants is to get the vaccine when it’s available to you.

Learn more about variants

About the Pfizer-BioNTech vaccine

Doses to be Fully Vaccinated
The Pfizer-BioNTech vaccine requires 2 doses about 21 days apart. It takes 14 days after your second dose to be protected from COVID-19.

How It Works
mRNA vaccines are introduced into the body to tell the body to make a harmless piece of “spike protein.” Your immune system sees the spike protein doesn’t belong in your body and starts building an immune response. This means that the next time you come in contact with the virus that causes COVID-19, your body knows how to fight it off. Scientists have been researching this type of vaccine for decades.

How Well It Works
In clinical trials, the Pfizer-BioNTech vaccine was 95% effective at preventing COVID-19 after two doses. It was equally effective among people of different races, ethnicities, genders and health conditions. The level of protection against the current variants of the virus are being tested.

Side Effects
Some participants in clinical trials showed a strong immune response, which often leads lead to some side effects. The second dose may result in a stronger immune response than the first dose. Side effects are normal and show that your body is building immunity to COVID-19.

Common side effects reported by some trial participants were:

  • Pain at the injection site (84.1%)
  • Fatigue (62.9%)
  • Headache (55.1%)
  • Chills (31.9%)
  • Joint Pain (23.6%)
  • Fever (14.2%)

Recommended for:

  • People of all races, ethnicities, and ages, 12 and older, including older adults
  • People with medical conditions
  • People who are pregnant and breastfeeding
  • People with weakened immune systems
  • People who had COVID-19 infection and have recovered

Not recommended for:
Children 11 years and younger. They started clinical trials with children under 12 years old in March 2021.

Talk to your health care provider if you:

  • Have had a serious allergic reaction to a vaccine or ingredients, including polyethylene glycol or polysorbate.
  • Have questions.

Ingredients
Similar to other vaccine ingredients: mRNA protein, fats, salts, and sugars. It contains polyethylene glycol and polysorbate. The vaccine does not have any fetal tissue, animal products, eggs, gelatin, latex, microchips, or preservatives.

About the Moderna Vaccine

Doses to be Fully Vaccinated
The Moderna vaccine requires two doses about 28 days apart. It takes 14 days after your second dose to be protected from COVID-19.

How it Works
mRNA vaccines are introduced into the body to tell the body to make a harmless piece of “spike protein.” Your immune system sees the spike protein doesn’t belong in your body and starts building an immune response. This means that the next time you come in contact with the virus that causes COVID-19, your body knows how to fight it off. Scientists have been researching this type of vaccine for decades.

How Well It Works
In clinical trials, the Moderna vaccine was 94% effective at preventing COVID-19 after two doses. It was highly effective among people of different races, ethnicities, ages, genders and medical conditions. The level of protection against the current variants of the virus are being tested.

Side Effects
Some participants in clinical trials showed a strong immune response, which often leads lead to some side effects. The second dose may result in a stronger immune response than the first shot. Side effects are normal and show that your body is building immunity to COVID-19.

Common side effects reported by some trial participants were:

  • Pain at the injection site (92%)
  • Fatigue (70%)
  • Headache (64.7%)
  • Muscle pain (61.5%)
  • Joint pain (46.4%)
  • Chills (45.4%)
  • Nausea/Vomiting (23%)
  • Fever (15.5%)

Recommended for:

  • People of all races, ethnicities, and ages, 18 and older, including older adults
  • People with medical conditions
  • People who are pregnant and breastfeeding
  • People with weakened immune systems
  • People who had COVID-19 infection and have recovered

Not recommended for:
Children 17 years and younger. Moderna is currently running clinical vaccine trials with adolescents aged 12 to 17. They also started a separate trial with children under 12 years old in March 2021.

Talk to your health care provider if you:

  • Had a serious allergic reaction to a vaccine or ingredients, including polyethylene glycol or polysorbate.
  • Have questions

Ingredients
Similar to other vaccine ingredients: mRNA protein, fats, salts, and sugars. It contains polyethylene glycol and polysorbate. The vaccine does not have any fetal tissue, animal products, eggs, gelatin, latex, microchips, or preservatives.

About the Janssen (Johnson & Johnson) Vaccine

Doses to be Fully Vaccinated
The Johnson & Johnson (Janssen Biotech, Inc.) vaccine requires one dose. It takes about 14 days after you get your vaccine to be protected.

How It Works
Vector vaccines use a modified virus like a cold virus that can’t make copies of itself or infect you. The vector virus tells your body to make harmless pieces of “spike proteins.” Your immune system sees the spike protein doesn’t belong in your body and starts building an immune response. This means that the next time you come in contact with the COVID-19 virus your body knows how to fight it off. Scientists have been researching this type of vaccine for decades. This type of vaccine was recently approved to prevent Ebola.

How Well It Works
In U.S. clinical trials, the Johnson & Johnson vaccine was 72% effective against moderate illness, was 85% effective against severe COVID-19 and 100% effective against hospitalization and death. These tests were done while the variants were circulating, so these efficacy rates take variants into account.

Side Effects
The FDA reports milder side effects than those found in the two-dose mRNA vaccines. Common side effects reported in clinical trials were:

  • Pain at the injection site (48.6%)
  • Tiredness (38.2%)
  • Headache (38.9)
  • Muscle pain (33.2%)
  • Nausea (14.2%)

As vaccinations are being administered across the country, a small number of people had a rare and severe type of blood clot up to 2 weeks after vaccination. This side effect is extremely rare. People who get a severe headache, abdominal pain, leg pain or shortness of breath within three weeks of receiving the Johnson & Johnson vaccine should immediately contact their health care provider.

Recommended for:

  • People of all races, ethnicities, and ages, 18 and older, including older adults.
  • People with medical conditions.
  • People who are pregnant and breastfeeding
  • People with weakened immune systems
  • People who had COVID-19 infection and have recovered

Not recommended for:
Children. Johnson & Johnson is running clinical vaccine trials with adolescents aged 12 to 17

Talk to your health care provider if you:

  • Had a serious allergic reaction to a vaccine or ingredients, including polysorbate.
  • Have questions

Ingredients
Similar to other vaccine ingredients: modified cold virus, proteins, fats, and salts. It contains polysorbate. The vaccine does not have any fetal tissue, pork products, eggs, gelatin, latex, microchips or preservatives.

Are the vaccines safe and effective?

Years of research into vaccines have brought us to where we are today. Scientists began researching coronavirus vaccines starting with Severe Acute Respiratory Syndrome (SARS) in 2003 and Middle East Respiratory Syndrome (MERS) in 2012. When these viruses disappeared, the pressure to find a coronavirus vaccine decreased. When COVID-19 was identified, the global focus on eliminating this new coronavirus and ending the pandemic, combined with large amounts of funding, helped speed up the research process to create a safe and effective vaccine.

Millions of people have been vaccinated safely. The vaccines are working in the real world. Studies show them to be more than 90% effective in real-world settings in preventing mild and severe disease, hospitalization and death. The vaccines have also proven to be effective against the COVID-19 variants that are currently circulating in the country.

The Pfizer-BioNTech vaccineModerna vaccine, and the Johnson & Johnson vaccine received Emergency Use Authorization from U.S. Food and Drug Administration.

Step 1: Vaccine Safety

With a brand new vaccine, researchers give it to a small number of volunteers — usually 20 to 100 — to test for any serious side effects. This step also helps determine the right dose or amount of vaccine to use.

Step 2: Vaccine Effectiveness

Once they know a vaccine isn’t likely to cause any serious side effects, researchers then give it to hundreds of people to determine how well the vaccine works (or its effectiveness). Researchers continue to monitor for any short-term side effects.

Step 3: Double Check Safety & Effectiveness

This is the last step before researchers can apply for approval from the FDA and begin to use it. To make sure the vaccine is safe and effective for people across ages, ethnicities, genders, and other factors, they give it to tens of thousands of people. This uncovers less common side effects and confirms once again that it’s safe and works well for everyone.

Step 4: Continue to Check Safety & Effectiveness:

Even after researchers have answered the big questions, they keep studying the vaccine. They gather longer-term data to make sure the vaccine continues to work well.

Sometimes, when a vaccine is urgently needed, researchers combine steps to speed up the approval process. This doesn’t mean that they’re skipping any important steps. It does mean researchers and public health organizations are working together at an extraordinary level to get a safe, e­ffective vaccine to the people who need it the most.

Why do I need two doses of the Pfizer or Moderna vaccine?

Both the Pfizer and Moderna vaccines require two doses, spaced about 3-4 weeks apart. We strongly recommend Vermonters get both doses for the highest level of protection from COVID-19.

Two doses of these vaccines are scientifically proven to be highly effective in preventing COVID-19. Since the beginning, we have followed the science. Participants in the clinical trials who did not receive both doses were not followed for a long period of time, so we do not know for sure about how well or how long one dose will protect you.

A two-dose vaccine is not new. For some vaccines, like hepatitis B, shingles and HPV, two doses produce a longer-lasting protection. While the first dose gets your immune system ready and offers some protection, the second dose boosts that protection by using your body’s new immune cells it created after the first dose. This “booster” increases the strength of your new antibody protection and makes it last longer.

Taking the full course of vaccine offers better protection against variants of the virus. In fact, being only partially vaccinated, for example getting only one dose of a two-dose vaccine, could increase the risk of vaccine-resistant variants of SARS-CoV-2, the virus that causes COVID-19. This is because the virus could be weakened with some antibody protection, but not stopped completely, creating the potential for the virus to mutate.

Some people experience stronger side effects after the second shot. Both the Pfizer and Moderna vaccines have equal doses in their first and second shots, but for some, stronger side effects are part of their body’s normal immune reaction to that “boost” in protection. Common side effects reported were pain at the injection site, fever, chills, tiredness and headache. These side effects typically go away within a few days.

Whether you experience side effects or not, rest assured the vaccine is working to protect you, your family and your community.

Do I need to continue prevention steps if I have been vaccinated?

You can choose to take the steps to prevent COVID-19 until you are fully vaccinated. You are fully vaccinated two weeks after your final shot. It takes time for the vaccine to train your body to fight COVID-19. 

If you are fully vaccinated (it's been 14 days since your final shot), you can go back to doing all the activities you did before the pandemic.

If you are fully vaccinated and then are a close contact of someone with COVID-19, you do not need to quarantine in certain situations. Learn more about what this means.

If you have a condition or are taking medications that weaken your immune system, you may not be fully protected even if you are fully vaccinated. Talk to your health care provider. Even after vaccination, you may choose to continue taking precautions.

There are still things we can all do to reduce the risk of getting or spreading COVID-19.

More vaccine resources

Vaccine Facts

Pfizer-BioNTech Vaccine Information

Moderna Vaccine Information

Johnson & Johnson Vaccine Information

After Vaccine Information

V-safe After Vaccination Health Checker (CDC) available in English, Simplified Chinese, Korean and Vietnamese.